Dynapres 0.4 Capsule PR Benefits & Uses

Dynapres 0.4 Capsule PR is used to treat the following -

Main Benefits

Enlarged Prostate

Dynapres 0.4 Capsule PR Dosage & How to Take

This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.

Find the right dosage based on disease and age

Age Group	Dosage
Adult(Male)	Disease: Before or After Meal: After Meal Single Maximum Dose: 0.4 mg Dosage Form: Tablet Dosage Route: Oral Frequency: 1 daily Course Duration: As directed by the doctor Special Instructions: For course duration follow doctor's advice
Geriatric	Disease: Before or After Meal: After Meal Single Maximum Dose: 0.4 mg Dosage Form: Tablet Dosage Route: Oral Frequency: 1 daily Course Duration: As directed by the doctor Special Instructions: For course duration follow doctor's advice

Dynapres 0.4 Capsule PR Side Effects

Based on research, the following side effects have been observed when Dynapres 0.4 Capsule PR is used -

Moderate

Ejaculation disorder

Mild

Back Pain (Read More - From Heat Therapy to Herbal Teas: Home Remedies for Back Pain)
Cough
Diarrhoea
Insomnia
Running nose
Sinus inflammation
Rash

Unknown

Impotence
Sore throat

Dynapres 0.4 Capsule PR Related Warnings

Is the use of Dynapres 0.4 Capsule PR safe for pregnant women?

The effects of Dynapres on pregnant women are unknown since no research has been done to ascertain it yet.

Unknown
Is the use of Dynapres 0.4 Capsule PR safe during breastfeeding?

Information about safety of Dynapres for women who are breastfeeding is not available since scientific research on this is yet to be done.

Unknown
What is the effect of Dynapres 0.4 Capsule PR on the Kidneys?

There are no side effects of Dynapres on the kidneys.

Safe
What is the effect of Dynapres 0.4 Capsule PR on the Liver?

Dynapres is not harmful for the liver.

Safe
What is the effect of Dynapres 0.4 Capsule PR on the Heart?

Dynapres is not harmful for the heart.

Safe

Severe Interaction of Dynapres 0.4 Capsule PR with Other Drugs

Dynapres 0.4 Capsule PR should not be taken with following medicines due to severe side effects it may cause to patients -

Severe

Doxazosin

Amiodarone

Moderate

Paracetamol,Chlorpheniramine,Dextromethorphan

Phenylephrine

Aliskiren

Amlodipine

Dynapres 0.4 Capsule PR Contraindications

If you are suffering from any of the following diseases, you should not take Dynapres 0.4 Capsule PR unless your doctor advises you to do so -

Prostate Cancer
Low Blood Pressure
Glaucoma
Liver Disease
Kidney Disease

Frequently asked Questions about Dynapres 0.4 Capsule PR

Is this Dynapres 0.4 Capsule PR habit forming or addictive?

Dynapres 0.4 Capsule PR does not cause addiction.

No
Is it safe to drive or operate heavy machinery when consuming?

Yes, you can operate a vehicle or heavy machinery after taking Dynapres 0.4 Capsule PR since it does not cause drowsiness.

Safe
Is it safe?

Dynapres 0.4 Capsule PR should be used only after doctor's advice.

Safe, but take only on Doctor's advise
Is it able to treat mental disorders?

Dynapres 0.4 Capsule PR is unable to treat or cure mental disorders.

No

Dynapres 0.4 Capsule PR Interactions with Food and Alcohol

Interaction between Food and Dynapres 0.4 Capsule PR

Taking Dynapres 0.4 Capsule PR with food is safe.

Safe
Interaction between Alcohol and Dynapres 0.4 Capsule PR

Taking alcohol with Dynapres 0.4 Capsule PR can be dangerous.

Severe

See all substitutes for Dynapres

This medicine data has been created by -

Vikas Chauhan

B.Pharma, Pharmacy
7 Years of Experience

References

US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Flomax® (tamsulosin hydrochloride)

KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 142-143

April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1172-1173